Professor Surendra Nath Pandeya (1939 – 2012) was an Indian medicinal and organic chemist. He made several contributions in the design and discovery of anticonvulsant, antitubercular, anti-HIV, anti-cancer, antibacterial, and antimicrobial molecules. His research focused on semicarbazones, Mannich bases, thiadiazoles, benzothiazoles, and oxindole compounds.
Early life and education
Dr. S.N. Pandeya was born in Ballia, India to Kapil Deo Pandey and Gangajali Devi Pandey. Dr. Pandeya attended Banaras Hindu University in 1954 to pursue both his BSc. and MSc He began his career with a two-year stint as a Lecturer at the University of Kharagpur and later returned to Banaras Hindu University where he completed his Ph.D. in organic chemistry in 1965 under Professor R.H. Sahasrabudhe.
Over his research career, Professor Pandeya worked and visited at several institutions, including: the UIC College of Pharmacy(1967 – 1968), the University of Georgia (1968 – 1969), and the University of Saskatchewan as a Canadian Commonwealth emeritus fellow (1992 – 1993). Additionally, he established several international collaborative efforts with organizations such as theNational Cancer Research Institute, National Institute of Neurological Disorders and Stroke (NINDS), and Katholieke Universiteit Leuven with world renowned Professor Erik De Clercq.
Professor Pandeya published over 275 research articles in peer-reviewed journals. He authored 18 books in the areas of medicinal and organic chemistry. His supervision led to the awarding of 22 Ph.D. and 75 M.Pharm. degrees.